Americana Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.92M Buy
31,396
+5,206
+20% +$780K 0.11% 141
2026
Q1
$4M Buy
26,190
+1,226
+5% +$188K 0.1% 149
2025
Q4
$3.44M Sell
24,964
-1,320
-5% -$173K 0.09% 166
2025
Q3
$3.37M Sell
26,284
-263
-1% -$32.1K 0.1% 159
2025
Q2
$3.21M Buy
26,547
+792
+3% +$89.3K 0.11% 157
2025
Q1
$2.87M Buy
25,755
+264
+1% +$28.1K 0.11% 145
2024
Q4
$2.48M Sell
25,491
-2,527
-9% -$269K 0.1% 165
2024
Q3
$3.22M Buy
28,018
+129
+0.5% +$14.6K 0.22% 105
2024
Q2
$2.97M Buy
27,889
+318
+1% +$31.9K 0.23% 105
2024
Q1
$2.67M Sell
27,571
-310
-1% -$31.8K 0.22% 113
2023
Q4
$2.82M Buy
27,881
+15,387
+123% +$1.49M 0.27% 93
2023
Q3
$1.26M Sell
12,494
-423
-3% -$42.9K 0.14% 135
2023
Q2
$1.3M Sell
12,917
-1,909
-13% -$191K 0.17% 122
2023
Q1
$1.36M Buy
14,826
+100
+0.7% +$8.73K 0.22% 107
2022
Q4
$1.33M Sell
14,726
-17,203
-54% -$1.45M 0.23% 100
2022
Q3
$2.43M Buy
31,929
+19,735
+162% +$1.64M 0.43% 72
2022
Q2
$994K Buy
12,194
+8,419
+223% +$739K 0.18% 110
2022
Q1
$328K Sell
3,775
-11,111
-75% -$962K 0.1% 172
2021
Q4
$1.3M Buy
14,886
+11,763
+377% +$977K 0.24% 99
2021
Q3
$255K Buy
+3,123
New +$281K 0.06% 209
2020
Q1
Sell
-98
Closed -$9K 378
2019
Q4
$9K Buy
+98
New +$8.79K 0.01% 438

Other funds holding NVS

Americana Partners's NVS Position: Q2 2026 in Review

Americana Partners increased its Novartis (NVS) stake by 20% in Q2 2026, buying an estimated $780K and bringing the position to 31,396 shares worth $4.92M. The position accounts for 0.11% of the portfolio, ranked #141.

Americana Partners first reported a position in NVS in Q4 2019 and has held it in 21 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Americana Partners held 31,396 shares of Novartis worth $4.92M as of Q2 2026.
  • Americana Partners bought 5,206 Novartis shares in Q2 2026, an estimated $780K.
  • Novartis made up 0.11% of Americana Partners's portfolio in Q2 2026, its #141 holding.
  • Americana Partners first reported a position in Novartis in Q4 2019 and has held it in 21 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.